Corrigendum to 'Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice'
Autor: | Shaoqun Tang, Hexiang Chen, Cheng Xu, Qingjian Liu, Yunzhao Yang, Xin Zeng, Chunchun Zhai |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
STAT3 Transcription Factor Immunology Blood Pressure Pharmacology Mice Text mining Pathology Medicine Animals Humans RB1-214 Interleukin 9 RNA Messenger STAT3 Cells Cultured Aged Mice Knockout biology business.industry Angiotensin II Interleukin-9 Cell Biology Middle Aged Blood pressure Hypertension biology.protein Cytokines business Corrigendum |
Zdroj: | Mediators of Inflammation, Vol 2020 (2020) Mediators of Inflammation |
ISSN: | 1466-1861 0962-9351 |
Popis: | Multiple interleukin (IL) family members were reported to be closely related to hypertension. We aimed to investigate whether IL-9 affects angiotensin II- (Ang II-) induced hypertension in mice.Mice were treated with Ang II, and IL-9 expression was determined. In addition, effects of IL-9 knockout (KO) on blood pressure were observed in Ang II-infused mice. To determine whether the effects of IL-9 on blood pressure was mediated by the signal transducer and activator of the transcription 3 (STAT3) pathway, Ang II-treated mice were given S31-201. Furthermore, circulating IL-9 levels in patients with hypertension were measured.Ang II treatment increased serum and aortic IL-9 expression in a dose-dependent manner; IL-9 levels were the highest in the second week and continued to remain high into the fourth week after the treatment. IL-9 KO downregulated proinflammatory cytokine expression, whereas it upregulated anti-inflammatory cytokine levels, relieved vascular dysfunction, and decreased blood pressure in Ang II-infused mice. IL-9 also reduced smooth muscle 22IL-9 KO alleviates inflammatory response, prevents phenotypic transformation of smooth muscle, reduces vascular dysfunction, and lowers blood pressure via the STAT3 pathway in Ang II-infused mice. IL-9 might be a novel target for the treatment and prevention of clinical hypertension. |
Databáze: | OpenAIRE |
Externí odkaz: |